Back

Medscape, LLC

  • Alzheimer Disease
  • Cognitive Dysfunction
  • Neuropsychological Tests

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer’s Disease

The goal of this activity is for learners to be better able to improve the timely diagnosis of early stages of AD by appropriately integrating clinical evidence of cognitive impairment with results from diagnostic biomarker testing.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Jun 25, 2026
  • Last day to claim credit
    Jun 26, 2027 9 months left